# FDA Inspection 1218953 - Bio-Heme - September 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/bio-heme/59e70bf4-cd33-44da-bfd7-7407e23eee6a
Source feed: FDA_Inspections

> FDA Inspection 1218953 for Bio-Heme on September 27, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218953
- Company Name: Bio-Heme
- Inspection Date: 2023-09-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1097868 - 2019-07-17](https://www.keypedia.com/records/fda_inspections/bio-heme/0a7dc098-b381-4d7a-844d-92f5f1952c90)
- [FDA Inspection 966890 - 2015-12-28](https://www.keypedia.com/records/fda_inspections/bio-heme/b8b2f6e2-d8bf-4d6a-8e21-f11e1e5c4749)
- [FDA Inspection 871854 - 2014-03-24](https://www.keypedia.com/records/fda_inspections/bio-heme/aadf91b6-b8b5-483b-b51d-acf857a065d7)
- [FDA Inspection 754410 - 2011-11-21](https://www.keypedia.com/records/fda_inspections/bio-heme/463394cb-fc50-4132-86b8-0cee91b73dcf)
- [FDA Inspection 640955 - 2010-01-26](https://www.keypedia.com/records/fda_inspections/bio-heme/d66d3eb5-cf50-4602-8804-0de79e580893)

Company: https://www.keypedia.com/companies/bio-heme/aa82739f-5555-4dd7-a1fd-3318b2fe43a2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d